FOLH1 and prostate carcinoma: This will undoubtedly be a benefit of the [123I]PSMA-p-IB ligand when used as a diagnostic for prostate cancer, as the location of the kidney is close to the prostate gland, thereby optimizing the prostate image during imaging due to the low accumulation of [123I]PSMA-p-IB in the kidney.